ABP-140

N/A

Report date: 2026/03/19 17:01:34

Base Information

Drug NameABP-140
Drug Alias NameABP-140
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-CD3Anti-CD38
TargetsT cell surface glycoprotein CD3Lymphocyte differentiation antigen CD38
Therapy Area/IndicationsProstatic NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbpro Corp
China Registration ClassN/A

Develop Information

Active CompaniesAbpro Corp
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A